Kirby McInerney LLP is investigating potential claims against the Board of Directors of Verenium Corporation (“Verenium” or the “Company”) (NASDAQ: VRNM) concerning the proposed acquisition of the Company by BASF Corporation. Under the terms of the proposed transaction, Verenium stockholders will receive $4.00 in cash for each share of Verenium owned, valuing the transaction at approximately $51 million. The investigation concerns whether Verenium’s Board of Directors violated its fiduciary duties by agreeing to this transaction and whether the proposed consideration adequately values Verenium’s common shares. If you are a shareholder of Verenium and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at email@example.com, by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form. Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.